Analysis: Reports of drug side effects increase fivefold in 12 years
More than 1 million reports of drug side effects were filed with the U.S. Food and Drug Administration in 2015, a fivefold increase since 20
top of page
Search
STAT News, Renee M. Landers
- Mar 20, 2017
- 2 min
Scott Gottlieb’s fervor for deregulation could harm patients
The Senate will soon begin the process of considering President Trump’s nomination of Dr. Scott Gottlieb, who has close professional and fin
5 views0 comments
The Cancer Letter, Matthew Bin Han Ong
- Feb 27, 2017
- 1 min
GAO: Power morcellation is a unique case study in patient harm
Power morcellators likely contributed to injury and deaths of hundreds of women, according to a new study by the Government Accountability O
17 views0 comments
National Public Radio, Richard Harris
- Feb 27, 2017
- 1 min
Advice from patients on a study's design makes for better science
Robert Comis describes the success of the NCI-MATCH trial and involving patient advocates in the process.
4 views0 comments
sg0251
- Feb 24, 2017
- 2 min
The USA Patient Network Asks Senators to Oppose the Right to Try Act
The USA Patient Network outlines the risks of supporting the Right to Try Act and asks senators to withdraw their support.
21 views0 comments
Our Bodies Our Selves, Amie Newman
- Feb 24, 2017
- 2 min
Trump’s plan for the FDA will make patients less safe
Read why President Trump's plan to streamline the FDA approval process will make patients less safe and will cause their health to suffe
21 views0 comments
sg0251
- Feb 22, 2017
- 2 min
USA Patient Network Thanks Senators For Not Co-Sponsoring Right to Try Act
The USA Patient Network thanks senators for not co-sponsoring the Trickett Wendler Right to Try Act because it would put patients in harm’s
32 views0 comments
Stat, Danielle Ofri
- Feb 16, 2017
- 1 min
The Joy of Hearing Patients Out
Read what happened when one doctor took the time to sit back and let their patients talk about their health uninterrupted.
4 views0 comments
Kaiser Health News, Liz Szabo
- Feb 9, 2017
- 1 min
Amid flurry of new cancer drugs, how many offer real benefits?
President Diana Zuckerman is cited in an article that discusses the effectiveness of recently approved oncology drugs that seem to offer lit
5 views0 comments
The Washington Post, Carolyn Y Johnson
- Feb 2, 2017
- 1 min
Trump calls for lower drug prices, fewer regulations in meeting with pharmaceutical executives
In a meeting with top pharmaceutical executives, President Trump offers no specific policies but emphasizes the need for lowering drug price
15 views0 comments
The New York Times, Katie Thomas
- Feb 1, 2017
- 1 min
Trump vows to ease rules for drug makers, but zeros in on prices
President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash reg
9 views0 comments
Natalya Estrada, Times Standard
- Jan 28, 2017
- 2 min
ACA repeal talk sparks fears among those with pre-existing conditions
Most health insurance companies also treated individual patients with pre-existing conditions differently than those that bought health insu
1 view0 comments
Kaiser Health News
- Jan 23, 2017
- 1 min
Trump’s HHS nominee prioritized profits over patients
As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he
10 views0 comments
Regulatory Affairs Professionals Society
- Jan 13, 2017
- 1 min
Analysis: Longer Review Times Associated With Fewer Adverse Events for High-Risk Heart Devices
A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event r
8 views0 comments
LA Times, Michael Hiltzik
- Jan 10, 2017
- 1 min
To appease a patient lobby, did the FDA approve a $300,000 drug that doesn't work?
The evidence supporting Exondys 51, an FDA approved drug meant to treat Duchenne muscular dystrophy, is too thin for a drug that costs $300,
15 views0 comments
Project on Government Oversight
- Jan 10, 2017
- 1 min
FDA Depends on Industry Funding; Money Comes with “Strings Attached”
The Food and Drug Administration's approval process is confusing, complicated and intertwined with lobbyists and top drug company execut
42 views0 comments
sg0251
- Jan 6, 2017
- 3 min
Comments of members of the USA Patient Network on Establishment of the Patient and Care-Partner Conn
Our comments are focused on the issues of inclusion and barriers to participation, but also on the broader issue of making sure that patient
13 views0 comments
Consumer Reports, Teresa Carr
- Jan 4, 2017
- 1 min
Off-Label Use: Should Drugs Do Double Duty?
Doctors often prescribe drugs "off label", meaning for purposes it wasn't approved for by the FDA. Most don't tell their p
11 views0 comments
sg0251
- Dec 5, 2016
- 3 min
USA Patient Network Letter to Senate asking to delay and fix 21st Century Cures Act
The USA Patient Network respectfully and strongly urges senators to vote against the 21st Century Cures Act this week, and instead insist th
87 views0 comments
Reuters Health, Andrew M. Seaman
- Dec 5, 2016
- 1 min
Cancer drugs may remain approved despite lack of benefit
In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies sho
9 views0 comments
bottom of page